share_log

Phoenix Rising Companies Announces Morpheus Robotics Acquisition Progress and Dental Implant Product Developments

Phoenix Rising Companies Announces Morpheus Robotics Acquisition Progress and Dental Implant Product Developments

鳳凰新星公司宣佈摩珀斯機器人收購進展和植牙產品開發
Accesswire ·  2022/10/13 23:10

PARK CITY, UT / ACCESSWIRE / October 13, 2022 / Phoenix Rising Companies OTCMarkets PINK:PRCX:

猶他州帕克城/訪問線/2022 年 10 月 13 日/ 鳳凰新星公司 OTC 市場粉紅色:PRCX:

DS Chang, CEO and Chairman of the company is pleased to announce progress towards the previously announced planned acquisition of Morpheus Robotics, Inc. Morpheus was originated and has continuing operations in Italy.

該公司首席執行官兼董事長 DS Chang 很高興地宣布對此前宣布計劃收購摩珀斯機器人公司 Morpheus 的進展起源於並在意大利持續經營業務。

While in the current pre-financing stage DS Chang continues to work with Massimo Strada and Stephen Lee of Morpheus. The Morpheus team has kept DS and Phoenix informed of ongoing advances in Morpheus product development.

而在目前的融資前階段 DS 張繼續與莫珀斯的馬西莫斯特拉達和斯蒂芬·李工作。摩珀斯團隊一直保持 DS 和鳳凰通知莫珀斯產品開發正在進行的進展.

The product of greatest interest currently is Morpheus' robotic devices for dental implantation. These machines, when finished and deployed, will aid oral surgeons to implant replacement teeth in patients with highly improve accuracy, greatly reducing both complications and pain. Further, use of the Morpheus machinery saves time and money.

目前最感興趣的產品是 Morpheus 用於牙科植入的機器人設備。這些機器在完成和部署後,將幫助口腔外科醫生在患者中植入替代牙齒,從而提高準確度,從而大大減少並發症和疼痛。此外,使用摩珀斯機械可以節省時間和金錢。

The Parties are working to complete the Share Exchange Agreement as soon as possible to be followed by the closing between the entities.

雙方正在努力盡快完成股份交換協議,以便隨後實體之間的關閉。

Further developments will be announced.

進一步的發展將公佈。

ABOUT MORPHEUS: Morpheus Medical Robotic System is the result of an unprecedented combination of Artificial Intelligence Based Software, new generation medical imaging, holographic reality, robotic applications, pervasive sensors natively integrated, delivering a new and unique minimally invasive robotic surgery ecosystem.

關於 MORPHEUS:Morpheus 醫療機器人系統是基於人工智能軟件,新一代醫學成像,全息現實,機器人應用,普遍集成的傳感器的前所未有結合的結果,提供了一個新的和獨特的微創機器人手術生態系統。

The Morpheus Super-Calculus GPU Based Appliance is a parallel vectorial supercomputing machine able to process 40 trillion operations per second guaranteeing a fluid ultra-high definition 4X4K, ultra-fast artificial intelligence segmentation, real-time Holographic mixed reality modeling, real-time visual guidance self-alignment.

Morpheus 超級微積分 GPU 設備是一種平行矢量超級計算機,每秒能夠處理 40 萬億次操作,保證流暢的超高清 4X4K,超快速的人工智能分割,實時全息混合現實建模,實時視覺引導自我對齊。

Morpheus started with and continues to use a primary engineering team in Milan, Italy.

Morpheus 從義大利米蘭開始並繼續使用一支主要工程團隊。

PHOENIX COMMENTS DS Chang, CEO of Phoenix reminds readers of his prior comments, to wit, "This acquisition, if completed, represents a move towards Westernizing Phoenix with new acquisitions that offer a substantial possibility of incredible growth of the company and its stake holders"

鳳凰評論鳳凰城首席執行官 DS Chang 提醒讀者他先前的評論,機智地說:「這次收購,如果完成,代表了通過新的收購項目向西化鳳凰城邁進,這為公司及其股份持有人提供了令人難以置信的增長的可能性」

For information on Phoenix Rising Companies, visit .
contact ir@phoenix-cos.com

有關鳳凰新星公司的信息,請訪問。
聯絡我們 ir@phoenix-cos.com

CAUTIONARY STATEMENT

警示性聲明

This press release contains forward-looking statements. Known and unknown risks may cause actual future results to vary widely. The statements are based upon Management's and Advisor's current expectations, estimates and projections; are not guarantees of future performance and are subject to certain risks and uncertainties and other factors, some of which are beyond Management's control and are difficult to predict. A reader of this press release should not place undue reliance on forward-looking statements. Investors should understand investing in shares of PRCX involves a high degree of risk and should seek competent investment advice prior to purchasing shares.

本新聞稿載有前瞻性陳述。已知和未知的風險可能導致未來實際的結果差異很大。這些聲明是基於管理層和顧問目前的期望,估計和預測; 並不保證未來的業績,並且受到某些風險和不確定性和其他因素的影響,其中一些因素超出了管理層的控制範圍,並且難以預測。本新聞稿的讀者不應對前瞻性陳述作出不當的依賴。投資者應明白投資於中國國際證券的股份涉及高度風險,並應在購買股份前尋求合格的投資意見。

SOURCE: Phoenix Rising Companies

來源: 鳳凰瑞星公司


View source version on accesswire.com:
檢視網站上的原始碼版本:

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論